1. Home
  2. LXRX

LXRX

Lexicon Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Founded: 1995 Country:
United States
United States
Employees: N/A City: THE WOODLANDS
Market Cap: 485.1M IPO Year: 2000
Target Price: $8.00 AVG Volume (30 days): 4.9M
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.80 EPS Growth: N/A
52 Week Low/High: $0.92 - $3.79 Next Earning Date: 04-30-2024
Revenue: $1,204,000 Revenue Growth: 766.19%
Revenue Growth (this year): 2086.71% Revenue Growth (next year): 168.47%

Share on Social Networks: